T. Ronan Kennedy - 28 Nov 2025 Form 4 Insider Report for cbdMD, Inc. (YCBD)

Reporting relationship: CEO and CFO, Director
Issuer ticker: YCBD
Reported as of: 28 Nov 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Dec 2025, 18:29:31 UTC
Prior SEC filing: 08 May 2025
Source filing: View source filing
Reporting owner signature: /s/ T. Ronan Kennedy

Key filing fact

T. Ronan Kennedy filed Form 4 for cbdMD, Inc. (YCBD) on 02 Dec 2025.

Key facts

This page summarizes T. Ronan Kennedy's Form 4 filing for cbdMD, Inc. (YCBD).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 02 Dec 2025, 18:29.

Change

Previous filing in this sequence was filed on 08 May 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001826452 Primary reporting owner

Kennedy Thomas Ronan

Relationship: CEO and CFO, Director
Address: 2101 WESTINGHOUSE BLVD. SUITE A, CHARLOTTE
Signature: /s/ T. Ronan Kennedy
Signature date: 02 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

YCBD transaction

Common Stock

Award

Transaction value
Shares: +445,000
Change %: +648%
Price
Shares after: 513,722
Date: 28 Nov 2025
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The shares of restricted stock were granted pursuant to the Issuer's 2025 Equity Compensation Plan. The vesting and issuance of the shares is subject to shareholder approval.

Footnote F2

The amount beneficially owned will not reconcile to the prior Form 4 due to a scriveners error.